Hillhouse Investment Management, Ltd.

Insider Reports History

Entity
Company
Location
Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands
Signature
Hillhouse Investment Management, Ltd., by /s/ Audrey Woon, Chief Compliance Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hillhouse Investment Management, Ltd.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enfusion, Inc. 10%+ Owner Class A common stock, par value $0.001 per share 4,975,183 $79.1 M $15.90 Oct 25, 2021 Indirect
ArriVent Biopharma, Inc. 10%+ Owner Common Stock 4,484,672 Jan 30, 2024 Indirect
ArriVent Biopharma, Inc. 10%+ Owner Series A Preferred Stock 0 Jan 30, 2024 Indirect
ArriVent Biopharma, Inc. 10%+ Owner Series B Preferred Stock 0 Jan 30, 2024 Indirect

Insider Reports Filed by Hillhouse Investment Management, Ltd.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVBP ArriVent Biopharma, Inc. Jan 30, 2024 5 9,999,990 4 Feb 1, 2024 10%+ Owner
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 0 3 Jan 25, 2024 10%+ Owner
ENFN Enfusion, Inc. Oct 25, 2021 1 -10,297,766 4 Oct 27, 2021 10%+ Owner
ENFN Enfusion, Inc. Oct 21, 2021 0 0 3 Oct 21, 2021 10%+ Owner